Silverback Therapeutics Inc

NASDAQ:SBTX   3:59:51 PM EDT
3.26
+0.01 (+0.31%)
Earnings Announcements

Silverback Therapeutics Reports Q1 2022 Results And Provides Business Update

Published: 05/12/2022 20:10 GMT
Silverback Therapeutics Inc (SBTX) - Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Silverback Therapeutics Inc- Qtrly Loss per Share $0.70.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.